Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

66.60p
   
  • Change Today:
    -0.50p
  • 52 Week High: 95.00
  • 52 Week Low: 60.70
  • Currency: UK Pounds
  • Shares Issued: 968.03m
  • Volume: 562,887
  • Market Cap: £644.71m
  • Beta: 0.01

Dr. Martens Overview

Dr. Martens operates in the global footwear market. Statista estimates that global retail sales of footwear in 2019 were £341 billion representing 12 billion pairs of footwear. Dr. Martens has a diversified global presence, with sales in more than 60 countries. The Group’s current geographical footprint, in terms of total Group revenue, is more weighted towards the US and EMEA, with APAC representing 20% of Dr. Martens’ FY20 revenue as compared to 29% for retail sales of the entire footwear market.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 3.4% 0.0%
Div Cover 1.6 n/a
Op Mrgn 7.5% n/a
ROCE 12.3%  
Latest F'cast
P/E 18.1 n/a
PEG 0.2 n/a
Pr/Revenue 1.0 n/a
Pr/Book 2.0  
Latest F'cast
Revenue -2.9% n/a
PBT 271.6% n/a
EPS 75.0% n/a
DPS n/a n/a

Dr. Martens Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-22 908.30 214.30 17.40p 13.7 0.3 +51% 5.50p 2.3%
31-Mar-23 1,000.30 159.40 12.90p 11.0 n/a -26% 5.84p 4.1%
31-Mar-24 877.10 93.00 7.40p 11.9 n/a -43% 2.55p 2.9%
30-Mar-25 787.60 8.80 2.40p 21.7 n/a -68% 2.55p 4.9%
29-Mar-26 764.90 32.70 4.20p 14.9 0.2 +75% 2.55p 4.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Dr. Martens Company Announcements

Admission to Trading 30-Sep-2026 09:19 RNS
Total Voting Rights 30-Sep-2026 09:06 RNS
Director/PDMR Shareholding 16-Sep-2026 13:50 RNS

Latest Dr. Martens Director Deals

Traded Action Notifier PriceAmountValue
11-Sep-26 Transfer From Giles Wilson 0.000p 231 £0.00
11-Sep-26 Buy Giles Wilson 64.70p 231 £149.46
11-Sep-26 Transfer From Ije Nwokori 0.000p 232 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 66.60p
Change Today -0.50p
% Change -0.75 %
52 Week High 95.00
52 Week Low 60.70
Volume 562,887
Shares Issued 968.03m
Market Cap £644.71m
Beta 0.01

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.68% below the market average52.68% below the market average52.68% below the market average52.68% below the market average52.68% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
55.11% below the market average55.11% below the market average55.11% below the market average55.11% below the market average55.11% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Income Not Available
Growth
12.82% above the market average12.82% above the market average12.82% above the market average12.82% above the market average12.82% above the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Aug-26 05-Mar-26
Paid 07-Oct-26 09-Apr-26
Amount 1.70p 0.85p

Trades for 02-Oct-2026

Time Volume / Share Price
16:35 172,509 @ 66.60p
16:35 997 @ 66.60p
16:35 1,330 @ 66.60p
16:35 1,252 @ 66.60p
16:35 518 @ 66.60p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page